A proposed Hodgkin’s lymphoma treatment returned positive test results in a clinical trial, according to drugmaker Seattle Genetics Inc., which seeks to file the drug for approval with the U.S. Food and Drug Administration next…
As the FDA considers the first genetically modified animal for human consumption, many in the seafood industry advocate for warning labels. But the biotech industry insists the fish are biologically identical to other Atlantic …
Was Johnson & Johnson aware of problems with its Children’s Tylenol months before the recall? The House Oversight Committee has invited an FDA commissioner and Johnson & Johnson chairman to a hearing next week to address this a…
Roche’s top-selling cancer-fighting drug Avastin has hit another roadblock in testing. In a Phase III study, Avastin failed to improve disease-free survival in early-stage colon cancer patients, the pharmaceutical giant reporte…
Another diet drug, Arena Pharmaceuticals’s Iorcaserin, appears to be in danger after a U.S. Food and Drug Administration advisory panel voted to reject it Thursday.
Continue reading FDA Panel Votes Against Aren…